Group Leader
                                            Juan Angel Recio Conde, Vicente García-Patos Briones                                        
                                            Researchers
                                            Kimberley MacGrail, Carlos González Cruz                                        
                                            PhD Students
                                            Paula Granado Martínez, Yuxin Ding, Berta Ferrer                                        
3
PUBLICATIONS
33.3%
%Q1
26
IMPACT FACTOR
8.77
AVERAGE IMPACT FACTOR
SELECTED ARTICLES
                                                        McGrail K, Granado-Martínez P, Esteve-Puig R, García-Ortega S, Ding Y, Sánchez-Redondo S, Ferrer B, Hernandez-Losa J, Canals F, Manzano A, Navarro-Sabaté A, Bartrons R, Yanes O, Pérez-Alea M, Muñoz-Couselo E, Garcia-Patos V, Recio JA.
                                                        BRAF activation by metabolic stress promotes glycolysis sensitizing NRASQ61-mutated melanomas to targeted therapy
                                                        Nat Commun. 2022 Nov 19;13(1):7113
                                                        DOI: doi: 10.1038/s41467-022-34907-0
                                                        IF: 17.690
                                                    
                                                        Gomez GVB, Lourenço GJ, Monteiro LMO, Rocha RS, Fernández KAM, Recio JA, Torricelli C, Coser LO, Oliveira ALR, Carron J, Moraes AM, Lima CSP.
                                                        Association of JAK/STAT genetic variants with cutaneous melanoma
                                                        Front Oncol. 2022 Aug 2;12:943483
                                                        DOI: doi: 10.3389/fonc.2022.943483
                                                        IF: 6.244
                                                    
                                                        Solé C, Domingo S, Penzo E, Moliné T, Porres L, Aparicio G, Ferrer B, Cortés-Hernández J.
                                                        Downregulation of miR-885-5p Promotes NF-κB Pathway Activation and Immune Recruitment in Cutaneous Lupus Erythematosus
                                                        J Invest Dermatol. 2023 Feb;143(2):209-219.e13.
                                                        DOI: doi: 10.1016/j.jid.2022.08.036
                                                        IF: 7.590
                                                    
                                                        Gómez-Tomás Á, Bouwes Bavinck JN, Genders R, González-Cruz C, de Jong E, Arron S, García-Patos V, Ferrándiz-Pulido C.
                                                        External Validation of the Skin and UV Neoplasia Transplant Risk Assessment Calculator (SUNTRAC) in a Large European Solid Organ Transplant Recipient Cohort
                                                        JAMA Dermatol. 2023 Jan 1;159(1):29-36.
                                                        DOI: doi: 10.1001/jamadermatol.2022.4820.
                                                        IF: 11.816
                                                    
                                                        Suñer C, Ubals M, Tarín-Vicente EJ, Mendoza A, Alemany A, Hernández-Rodríguez Á, Casañ C, Descalzo V, Ouchi D, Marc A, Rivero À, Coll P, Oller X, Miguel Cabrera J, Vall-Mayans M, Dolores Folgueira M, Ángeles Melendez M, Agud-Dios M, Gil-Cruz E, Paris de Leon A, Ramírez Marinero A, Buhiichyk V, Galván-Casas C, Paredes R, Prat N, Sala Farre MR, Bonet-Simó JM, Farré M, Ortiz-Romero PL, Clotet B, García-Patos V, Casabona J, Guedj J, Cardona PJ, Blanco I; Movie Group; Marks M, Mitjà O
                                                        Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain
                                                        Lancet Infect Dis. Apr;23(4):445-453.
                                                        DOI: doi: 10.1016/S1473-3099(22)00794-0
                                                        IF: 71.421
                                                    
                                            Oncogene-mediated intratumoral immune-cell populations at different organs as biomarkers of immunotherapy response
                                            Principal Investigator: Juan Angel Recio Conde
                                                                                            Agency: Instituto de Salud Carlos III
                                                                                                                                        Funding: 341,220 €
                                                                                                                                        Period: 01/01/2021 - 31/12/2023
                                                                                    
                                            p38alpha in control of UV-induced melanoma development
                                            Principal Investigator: Juan Angel Recio Conde
                                                                                            Agency: Fundacion Ramon Areces
                                                                                                                                        Funding: 129,371 €
                                                                                                                                        Period: 31/01/2019 - 31/01/2022
                                                                                    
                                            Molecular mechanisms in melanoma
                                            Principal Investigator: Juan Angel Recio Conde
                                                                                            Agency: Generalitat de Catalunya - 2021 SGR 00653
                                                                                                                                        Funding: 60,000 €
                                                                                                                                        Period: 31/01/2021 - 31/01/2023